Bonine Tablet, Chewable
Product Images NDC 65197-296

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bonine (NDC 65197-296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wellspring Pharmaceutical Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

16 Ct Carton Label (Bonine 1)

16 Ct Carton Label (Bonine 1)
This is an advertisement for Bonine, an antiemetic medication containing Meclizine Hydrochloride that claims to be less drowsy than Dramamine for treating motion sickness-induced nausea, dizziness, and vomiting. The rest of the text seems to contain random characters or codes that are not related to the drug.*
FDA Label Image

8 Count Carton (Bonine 2)

8 Count Carton (Bonine 2)
This is an over-the-counter medicine, which is marketed to prevent or treat motion sickness symptoms like nausea, dizziness, and vomiting. The medicine is advertised as being less drowsy as compared to Dramamine®. The key active ingredient in this medicine is Meclizine Hydrochloride, which is an antiemetic drug. The medicine is available in the form of raspberry-flavored chewable tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.